How often can I take Zofran 4 mg for nausea

How often can I take Zofran 4 mg for nausea?

On the average, zofran is taken twice a day for four days. If you are vomiting or have persistent nausea and are still vomiting after four days, you may want to talk to your doctor about what else they may recommend. You may be able to try an over-the-counter nausea medication to see if they are any more effective.

How often can I take Zofran mg for nausea before I go to bed?

If you are having nausea as a result of chemotherapy be sure to talk to your doctor about any medications they can prescribe to help with your symptoms. However, Zofran is not a good choice for nausea from chemotherapy if it makes you sleepy. It can also cause drowsiness, so it's best not to take it within a couple of hours of bedtime.

How often do you take Zofran mg for nausea in pregnancy?

Zofran (ondansetron) is usually taken every 4-8 hours to treat nausea and vomiting caused by chemotherapy drugs, motion sickness, or pregnancy. You may be able to take Zofran as often as every four hours if the nausea becomes too severe. Ask your doctor if it’s safe to take Zofran every two hours, especially in the middle of the night if you’re having trouble sleeping.

How often to

The recommended starting dose for Zofran 4 mg is 4 mg every 12 hours for three days. If you find that this dose causes intractable nausea and vomiting, your doctor may decide to change the dose. You may be able to increase the dose by one dose every two days until you find the dose that works best for your symptoms. If you need any higher than 4 mg for more control of nausea and vomiting, talk to your doctor.

How often do you take Zofran mg for nausea?

Doctors generally prescribe Zofran 4 mg twice a day for four to five days for an early stage of chemotherapy-induced nausea and vomiting (CINV). If you continue to experience nausea after the first four days of taking the drug, talk to your doctor about an increased dose of Zofran (8 mg) or adding a follow-up drug such as ondansetron.